litlas
ログインアカウント作成

Beverly A. Teicher

1980–2025 年に発表

109
論文数
17,904
被引用数
77
h 指数
105
i10 指数

被引用数

Beverly A. Teicher の年別被引用数1981 年: 被引用 7 件1982 年: 被引用 6 件1983 年: 被引用 3 件1984 年: 被引用 8 件1985 年: 被引用 4 件1986 年: 被引用 7 件1987 年: 被引用 20 件1988 年: 被引用 22 件1989 年: 被引用 26 件1990 年: 被引用 36 件1991 年: 被引用 40 件1992 年: 被引用 35 件1993 年: 被引用 39 件1994 年: 被引用 58 件1995 年: 被引用 61 件1996 年: 被引用 53 件1997 年: 被引用 50 件1998 年: 被引用 59 件1999 年: 被引用 60 件2000 年: 被引用 89 件2001 年: 被引用 97 件2002 年: 被引用 71 件2003 年: 被引用 113 件2004 年: 被引用 100 件2005 年: 被引用 100 件2006 年: 被引用 103 件2007 年: 被引用 112 件2008 年: 被引用 112 件2009 年: 被引用 96 件2010 年: 被引用 90 件2011 年: 被引用 103 件2012 年: 被引用 109 件2013 年: 被引用 106 件2014 年: 被引用 116 件2015 年: 被引用 108 件2016 年: 被引用 124 件2017 年: 被引用 149 件2018 年: 被引用 146 件2019 年: 被引用 406 件2020 年: 被引用 499 件2021 年: 被引用 491 件2022 年: 被引用 459 件2023 年: 被引用 311 件2024 年: 被引用 454 件2025 年: 被引用 223 件2026 年: 被引用 3 件

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,324 件、この内訳の 32.7%中国: 引用元論文 793 件、この内訳の 11.2%イギリス: 引用元論文 453 件、この内訳の 6.4%ドイツ: 引用元論文 389 件、この内訳の 5.5%イタリア: 引用元論文 331 件、この内訳の 4.7%カナダ: 引用元論文 249 件、この内訳の 3.5%日本: 引用元論文 235 件、この内訳の 3.3%フランス: 引用元論文 222 件、この内訳の 3.1%オランダ: 引用元論文 170 件、この内訳の 2.4%オーストラリア: 引用元論文 155 件、この内訳の 2.2%スペイン: 引用元論文 153 件、この内訳の 2.1%インド: 引用元論文 131 件、この内訳の 1.8%
0%32.7%その他 21.1%

機関

分野

  • Medicine50.7%
  • Biochemistry, Genetics and Molecular Biology34.1%
  • Immunology and Microbiology5%
  • Engineering2.8%
  • Materials Science1.7%
  • Computer Science1.3%
  • その他4.4%

トピック

  • Cancer, Hypoxia, and Metabolism3.7%
  • PARP inhibition in cancer therapy3.2%
  • Angiogenesis and VEGF in Cancer2.5%
  • Lung Cancer Research Studies2.2%
  • Cancer Cells and Metastasis2.1%
  • DNA Repair Mechanisms2%
  • その他84.3%

共著者

全論文

検索で開く
  1. A Menin-MLL Inhibitor Induces Specific Chromatin Changes and Eradicates Disease in Models of MLL-Rearranged Leukemia

    著者: Andrei V. Krivtsov, Kathryn Evans, Jayant Y. Gadrey, Benjamin K. Eschle, Charlie Hatton, Hannah J. Uckelmann, Kenneth N. Ross, Florian Perner, Sarah Naomi Olsen, Tara Pritchard, Lisa McDermott, Connor Jones, Duohui Jing, Ali Braytee, Diego Chacon Fajardo, Eric J. Earley, Brian M. McKeever, David A. Claremon, Andrew J. Gifford, Heather Lee, Beverly A. Teicher, John E. Pimanda, Dominik Beck, Jennifer A. Perry, Malcolm A. Smith, Gerard M. McGeehan, Richard B. Lock, Scott A. Armstrong - Cancer Cell 2019 被引用: 449

  2. CXCL12 (SDF-1)/CXCR4 Pathway in Cancer

    著者: Beverly A. Teicher, Simon P. Fricker - Clinical Cancer Research 2010 被引用: 1,468

  3. Antibody–drug conjugates for cancer therapy

    著者: Anish Thomas, Beverly A. Teicher, Raffit Hassan - The Lancet Oncology 2016 被引用: 588

  4. PARP Inhibitor Activity Correlates with SLFN11 Expression and Demonstrates Synergy with Temozolomide in Small Cell Lung Cancer

    著者: Benjamin H. Lok, Eric E. Gardner, Valentina E. Schneeberger, Ai Ni, Patrice Desmeules, Natasha Rekhtman, Elisa de Stanchina, Beverly A. Teicher, Nadeem Riaz, Simon N. Powell, John T. Poirier, Charles M. Rudin - Clinical Cancer Research 2016 被引用: 334

  5. Stereospecific PARP Trapping by BMN 673 and Comparison with Olaparib and Rucaparib

    著者: Junko Murai, Shar-yin N. Huang, Amèlie Renaud, Yiping Zhang, Jiuping Ji, Shunichi Takeda, Joel Morris, Beverly A. Teicher, James H. Doroshow, Yves Pommier - Molecular Cancer Therapeutics 2013 被引用: 758

  6. SCLC-CellMiner: A Resource for Small Cell Lung Cancer Cell Line Genomics and Pharmacology Based on Genomic Signatures

    著者: Camille Tlemsani, Lőrinc Sándor Pongor, Fathi Elloumi, Luc Girard, Kenneth E. Huffman, Nitin Roper, Sudhir Varma, Augustin Luna, Vinodh N. Rajapakse, Robin Sebastian, Kurt W. Kohn, Julia Krushkal, Mirit I. Aladjem, Beverly A. Teicher, Paul S. Meltzer, William C. Reinhold, John D. Minna, Anish Thomas, Yves Pommier - Cell Reports 2020 被引用: 168

  7. The B7-H3–Targeting Antibody–Drug Conjugate m276-SL-PBD Is Potently Effective Against Pediatric Cancer Preclinical Solid Tumor Models

    著者: Nathan M. Kendsersky, Jarrett M. Lindsay, E. Anders Kolb, Malcolm A. Smith, Beverly A. Teicher, Stephen W. Erickson, Eric J. Earley, Yaël P. Mossé, Daniel Martínez, Jennifer Pogoriler, Kateryna Krytska, Khushbu Patel, David Groff, Matthew Tsang, Samson Ghilu, Yifei Wang, Steven Seaman, Yang Feng, Brad St. Croix, Richard Görlick, Raushan T. Kurmasheva, Peter J. Houghton, John M. Maris - Clinical Cancer Research 2021 被引用: 122

  8. Antibody Conjugate Therapeutics: Challenges and Potential

    著者: Beverly A. Teicher, Ravi Chari - Clinical Cancer Research 2011 被引用: 422

  9. Immuno-transcriptomic profiling of extracranial pediatric solid malignancies

    著者: Andrew S. Brohl, Sivasish Sindiri, Jun S. Wei, David Milewski, Hsien-Chao Chou, Young Song, Xinyu Wen, Jeetendra Kumar, Hue V. Reardon, Uma Mudunuri, Jack Collins, Sushma Nagaraj, Vineela Gangalapudi, Manoj Tyagi, Yuelin J. Zhu, Katherine E. Masih, Marielle E. Yohe, Jack F. Shern, Yue Qi, Udayan Guha, Daniel Catchpoole, Rimas J. Orentas, Igor B. Kuznetsov, Nicolás J. Llosa, John A. Ligon, Brian Turpin, Daniel Leino, Shintaro Iwata, Irene L. Andrulis, Jay S. Wunder, Sílvia Regina Caminada de Toledo, Paul S. Meltzer, Ching C. Lau, Beverly A. Teicher, Heather Magnan, Marc Ladanyi, Javed Khan - Cell Reports 2021 被引用: 71

  10. Small Cell Lung Cancer Screen of Oncology Drugs, Investigational Agents, and Gene and microRNA Expression

    著者: Eric C. Polley, Mark W. Kunkel, David M. Evans, Thomas Silvers, René Delosh, Julie Laudeman, Chad Ogle, Russell Reinhart, Michael Selby, John Connelly, Erik Harris, Nicole Fer, Dmitriy Sonkin, Gurmeet Kaur, Anne Monks, Shakun Malik, Joel Morris, Beverly A. Teicher - JNCI Journal of the National Cancer Institute 2016 被引用: 173

  11. Antibody-drug Conjugate Targets, Drugs, and Linkers

    著者: Beverly A. Teicher, Joel Morris - Current Cancer Drug Targets 2022 被引用: 34

  12. Comprehensive characterization of the Published Kinase Inhibitor Set

    著者: Jonathan M. Elkins, Vita Fedele, M. Szklarz, Kamal R. Abdul Azeez, E. Salah, Jowita Mikolajczyk, Sergei Romanov, Nikolai Sepetov, Xi‐Ping Huang, Bryan L. Roth, Ayman Al Haj Zen, Denis Fourches, Eugene Muratov, Alex Tropsha, Joel Morris, Beverly A. Teicher, Mark W. Kunkel, Eric C. Polley, Karen Lackey, Francis Atkinson, John P. Overington, Paul Bamborough, Susanne Müller, Daniel J. Price, Timothy M. Willson, David H. Drewry, Stefan Knapp, William J. Zuercher - Nature Biotechnology 2015 被引用: 350

  13. Epigenome-wide DNA methylation analysis of small cell lung cancer cell lines suggests potential chemotherapy targets

    著者: Julia Krushkal, Thomas Silvers, William C. Reinhold, Dmitriy Sonkin, Suleyman Vural, John Connelly, Sudhir Varma, Paul S. Meltzer, Mark W. Kunkel, Annamaria Rapisarda, David M. Evans, Yves Pommier, Beverly A. Teicher - Clinical Epigenetics 2020 被引用: 87

  14. Hypoxia and drug resistance

    著者: Beverly A. Teicher - Cancer and Metastasis Reviews 1994 被引用: 563

  15. OBI-3424, a Novel AKR1C3-Activated Prodrug, Exhibits Potent Efficacy against Preclinical Models of T-ALL

    著者: Kathryn Evans, JianXin Duan, Tara Pritchard, Connor Jones, Lisa McDermott, Zhaohui Gu, Cara E. Toscan, Narimanne El-Zein, Chelsea Mayoh, Stephen W. Erickson, Yuelong Guo, Fanying Meng, Donald Jung, Komal S. Rathi, Kathryn G. Roberts, Charles G. Mullighan, Chi‐Sheng Shia, Tillman Pearce, Beverly A. Teicher, Malcolm A. Smith, Richard B. Lock - Clinical Cancer Research 2019 被引用: 53

  16. TGFβ-Directed Therapeutics: 2020

    著者: Beverly A. Teicher - Pharmacology & Therapeutics 2020 被引用: 87

  17. CD248: A therapeutic target in cancer and fibrotic diseases

    著者: Beverly A. Teicher - Oncotarget 2019 被引用: 79

  18. Tumor Evasion of the Immune System by Converting CD4+CD25− T Cells into CD4+CD25+ T Regulatory Cells: Role of Tumor-Derived TGF-β

    著者: Victoria C. Liu, Larry Wong, Thomas L. Jang, Ali Shah, Irwin Park, Ximing J. Yang, Qiang Zhang, Scott Lonning, Beverly A. Teicher, Chung Lee - The Journal of Immunology 2007 被引用: 440

  19. Endosialin/TEM 1/CD248 is a pericyte marker of embryonic and tumor neovascularization

    著者: Rebecca G. Bagley, Nakayuki Honma, William Weber, Paula Boutin, Cécile Rouleau, Srinivas Shankara, Shiro Kataoka, Isao Ishida, Bruce Roberts, Beverly A. Teicher - Microvascular Research 2008 被引用: 115

  20. Proteasome inhibitors

    著者: Beverly A. Teicher, Joseph E. Tomaszewski - Biochemical Pharmacology 2015 被引用: 168

  21. Broad Spectrum Activity of the Checkpoint Kinase 1 Inhibitor Prexasertib as a Single Agent or Chemopotentiator Across a Range of Preclinical Pediatric Tumor Models

    著者: Caitlin D. Lowery, Michele Dowless, Matthew Renschler, Wayne Blosser, Alle B. VanWye, Jennifer R. Stephens, Philip W. Iversen, Aimee Bence Lin, Richard P. Beckmann, Kateryna Krytska, Kristina A. Cole, John M. Maris, Douglas S. Hawkins, Brian P. Rubin, Raushan T. Kurmasheva, Peter J. Houghton, Richard Görlick, E. Anders Kolb, Min H. Kang, C. Patrick Reynolds, Stephen W. Erickson, Beverly A. Teicher, Malcolm A. Smith, Louis F. Stancato - Clinical Cancer Research 2018 被引用: 80

  22. ABBV-085, Antibody–Drug Conjugate Targeting LRRC15, Is Effective in Osteosarcoma: A Report by the Pediatric Preclinical Testing Consortium

    著者: Pooja Hingorani, Michael Roth, Yifei Wang, Wendong Zhang, Jonathan Gill, Douglas J. Harrison, Beverly A. Teicher, Stephen W. Erickson, Gregory J. Gatto, Malcolm A. Smith, E. Anders Kolb, Richard Görlick - Molecular Cancer Therapeutics 2020 被引用: 37

  23. Evaluation of an EZH2 inhibitor in patient-derived orthotopic xenograft models of pediatric brain tumors alone and in combination with chemo- and radiation therapies

    著者: Qi Lin, Holly Lindsay, Mari Kogiso, Yuchen Du, Frank Braun, Huiyuan Zhang, Lei Guo, Sibo Zhao, Sarah G. Injac, Patricia Baxter, Jack Su, Sophie Xiao, Stephen W. Erickson, Eric J. Earley, Beverly A. Teicher, Malcolm A. Smith, Xiao‐Nan Li - Laboratory Investigation 2021 被引用: 26

  24. Integrative epigenomic analyses of small cell lung cancer cells demonstrates the clinical translational relevance of gene body methylation

    著者: Lőrinc Sándor Pongor, Camille Tlemsani, Fathi Elloumi, Yasuhiro Arakawa, Ukhyun Jo, Jacob Gross, Sara Mosavarpour, Sudhir Varma, Rahul K. Kollipara, Nitin Roper, Beverly A. Teicher, Mirit I. Aladjem, William C. Reinhold, Anish Thomas, John D. Minna, Jane E. Johnson, Yves Pommier - iScience 2022 被引用: 23